Abstract Personalized therapies play an increasingly critical role in cancer care: Image guidance with multimodality image fusion facilitates the targeting of specific tissue for tissue characterization and plays a role in drug discovery and optimization of tailored therapies. Positronemission tomography (PET), magnetic resonance imaging (MRI), and contrast-enhanced computed tomography (CT) may offer additional information not otherwise available to the operator during minimally invasive image-guided procedures, such as biopsy and ablation. With use of multimodality image fusion for image-guided interventions, navigation with advanced modalities does not require the physical presence of the PET, MRI, or CT imaging system. Several commercially available methods of image-fusion and device navigation are reviewed along with an explanation of common tracking hardware and software. An overview of current clinical applications for multimodality navigation is provided.
Introduction
Personalized therapies play an increasingly critical role in cancer care [1] [2] [3] : Image guidance with multimodality image fusion facilitates the targeting of specific tissue for molecular profiling and characterization and plays a role in drug discovery and optimization of tailored therapies. Positron emission tomography (PET) fusion-guided biopsy procedures are based on either electromagnetic (EM) tracking or cone-beam CT (CBCT) registration and enable sampling of a specific area within a tumor based on metabolic activity by prospectively correlating pathology to imaging, such as PET activity [4] . PET, magnetic resonance imaging (MRI), and contrast-enhanced CT may offer additional information not otherwise available to the operator during minimally invasive image-guided procedures, such as biopsy and ablation. With use of multimodality image fusion for image-guided interventions, navigation with advanced modalities does not require the physical presence of the PET, MRI, or CT imaging system. Several commercially available methods of image-fusion and device navigation are reviewed along with an explanation of common tracking hardware and software. An overview of current clinical applications for multimodality navigation is provided. Image fusion has been implemented in clinical trials for the past 8 years for biopsy and ablation procedures and has been used as a research tool to prospectively correlate imaging features with biomarkers or drug effects [5] . Although speculative at present, multimodality fusion guidance may enable procedures that would otherwise not be possible [6] or that may decrease patient and operator radiation dose, volume of contrast, and complication rates. Planning multiple overlapping composite treatment zones may also improve the success of large-volume tumor ablation.
Background on Image Fusion-Guided Procedures
Image fusion and coregistration bring several imaging modalities together. Although the terms are often used interchangeably, image fusion is the overlay of two or more imaging data sets together, as one display, whereas image coregistration consists of aligning or matching the two imaging data sets spatially to each other [7] . Registration can be rigid or elastic (deformable). Only translation (panning) and rotation are possible with rigid coregistration whereas rotation, translation, and localized stretching are possible with elastic registration, which improves matching of anatomical structures. For example, a difference in patient positioning between diagnostic and intraprocedural imaging may be corrected by rotating the image, but a deformation of an organ secondary to placement of a rigid probe or a stent-graft would require localized stretching [8] . Motion associated with position, organ shift or deformation, and respiratory movement present ongoing challenges to image registration and fusion [7] . Despite practical limitations, image fusion and registration can improve visualization during image-guided procedures, which may in turn improve accuracy by decreasing the number of device repositionings required to reach a target by allowing physician to precisely navigate to a lesion on PET without anatomical correlate on conventional imaging, etc. Accuracy may translate into other clinical benefits, such as shorter procedure time and decreased amount of radiation to both patients and staff.
Multimodality Image-Fusion Navigation Systems
There are several methods by which to enable navigation during image-guided procedures with codisplay of multiple data sets. Each method includes (1) the capability to import previously acquired image data sets to be registered with a selected real-time imaging modality; and (2) the ability to display the position of the procedure device in the fused data sets in static or real-time fashion. Electromagnetic (EM) tracking and optical tracking provide real-time position data for tracked instruments in a virtual space, whereas cone-beam CT (CBCT)-based navigation permits registration of 3D data sets with fluoroscopy for real-time instrument localization.
EM Tracking
EM tracking is sometimes referred to as ''medical GPS'' [8, 9] and relies on Faraday's law of induction. A generator creates numerous weak and differential magnetic fields that turn on and off within a work volume of approximately 500 9 500 9 500 mm. A coil within that magnetic field evokes a weak detectable electrical current, whose signal strength is related to the coil's location within this changing magnetic field. This changing current is detected and its strength is triangulated and defined by a point in space. This basic physics principle is used to define the coil and device locations within a Cartesian coordinate system [8, 9] . Several coils can be tracked simultaneously. The coils are integrated within medical devices and fiducial skin patches.
EM tracking requires additional equipment relative to that necessary for a conventional image-guided biopsy procedure, including a tracking workstation, field generator, and specialized disposables and nondisposables, such as tracked needles, stylettes, ultrasound guides, and fiducial patches [9] . However, it offers the advantages of both multimodality image-fusion and real-time display during an intervention, as well as real-time device tracking, compared with only intermittent displays of needle angle and position during a conventional percutaneous intervention. Navigation with EM tracking can be accomplished with several different workflows, depending on the realtime modality and the fusion modalities. In many cases, radio-opaque fiducial patches equipped with sensor coils are placed in the area of interest and used for registration, which is achieved by matching their position on procedural imaging to the actual location as detected by the field generator (and verified by tapping on the fiducial patches with a pointer). A tracked ultrasound probe can also be used for real-time fusion imaging to act as a ''multiplanar reconstruction (MPR) plane selector'' (Fig. 1) . A procedural CT or ultrasound (US) may be registered to previous imaging modalities, such as PET-CT or MRI, using anatomical landmarks or scan-plane matching, and automated registration tools are under development that will facilitate throughput immensely. Tracked devices are navigated to a target, based on the fused modalities, with real-time feedback of the position of the device in relation to the fused modalities.
The registration error is an approximate measure of the difference between the fiducial skin patches' selected positions and their positions as calculated by the tracking software. Thus, the registration error represents approximately how well the positional coordinates of the selected imaging modalities are overlaid. For example, a registration error \2 mm is required, but it is not necessarily synonymous with clinical accuracy. The target to registration error is measured by comparing the difference of the reported tracked device location with its actual position on verification CT [8, 10] . The overall clinical error depends on the registration error, the target-to-registration error, and operator error and is sometimes measured as the distance of the needle tip to a desired point target. EM-tracking registration may be hampered by degradation of coil signal (and registration) secondary to the equipment's proximity to metallic structures, e.g., the CT gantry. Most electromagnetic systems have a dynamic registration patch that corrects for patient motion; some systems also offer respiratory gating. Nonetheless, respiratory motion and uncorrected organ shifts will influence the target to registration error and overall accuracy.
Optical Tracking
Optical systems are inspired by parallax satellite systems and use infrared or laser light-emitting diodes localized on (or reflected from) instruments within the field of view of an infrared camera [11, 12] . The infrared light floods a predetermined work volume and reflects back to the camera by way of reflective coating on passive tracking markers. Alternatively, active tracking markers can initiate their own light or infrared signal. The tracking markers placed on surgical instruments report and transmit their position and data to the workstation.
Similar to EM tracking, imaging data sets can be obtained and transferred to the tracking workstation for coregistration, fusion or multiplanar display, and real-time navigation. The advantage of optical systems is higher accuracy; however, their widespread use has been precluded by the ''line of sight'' requirement, which is the necessity of a direct unimpeded pathway between camera and tracked instrument [8, 11, 12] . This limitation precludes tracking the internal portions of the devices (such as the tip of a flexible bent needle) [12] . The back end (i.e., needle hub) can be optically tracked, and if the instrument is absolutely rigid (nonflexible and nondeformable), then its internal location (i.e., needle tip location) can be automatically extrapolated.
CBCT-Based Navigation
CBCT is a three-dimensional (3D) data set generated from the rotation of the X-ray source and flat detector (FD) integrated in the angiography/fluoroscopy C-arm suite. CBCT-based navigation technology can be a tool for needle or catheter guidance to a target that may be defined on intraprocedural CBCT or previous MRI, PET-CT, or CT. Coregistering live-fluoroscopy with CBCT 3D volume reconstructed from the detector rotation allows the operator to reference the fused imaging during fluoroscopy to Fiducial patches are placed in the region of interest, and a procedural CT scan is obtained. The fiducial patches are used to register the CT in the magnetic space because they contain sensor coils and are radioopaque. Previous imaging may also be registered rigidly with procedural CT using anatomical landmarks. B EM field generator (circled in blue near the top center of image) as well as tracked devices and the fiducial patches (yellow arrow in center of image). All tracked devices within the field of view of the EM generator will be displayed on procedural CT or other advanced imaging that was fused combine fusion guidance with real time X-ray guidance. The images of the CBCT or previously acquired imaging (such as MRI or CT) may be used to determine a target, e.g., a skin entry point, and plan a path for a device, needle, or catheter. The selected virtual device path is simultaneously displayed on real-time fluoroscopy in addition to the fused image (previous 3D data set), thus enabling complex image-based navigation in the angiography suite [13] .
Several methods are available for needle or catheter navigation with fused CBCT. Tumor segmentation can be performed and incorporated into the planning CBCT images to more accurately plan and accomplish ablation or combinational treatment procedures (Fig. 2 ). For needlebased procedures, the virtual planned path may be displayed in conjunction with the coregistered data and tumor. For vascular procedures, the target vessels can be identified and isolated semiautomatically with standard processing and segmentation tools (such as ordered region growing). The catheter path may then be displayed on fluoroscopy during selective catheterization. This virtual path and coregistered images adjust with movement of the C-arm or table assuming patient immobility. One major limitation of CBCT-based navigation is the assumption of immobility and rigidity of anatomy, although this is a limitation of all navigation systems, including optical tracking and EM tracking. With EM tracking, ''dynamic reference tracking'' can be used where a tracker is attached to the patient to correct for patient motion. The patient must be kept immobile to ensure that CBCT planned ''virtual'' path remains rigidly coregistered to the actual anatomy. Any patient movement will require manual correction or repeat registration [13] . Immobilization pads and ''beanbags'' often used in radiation therapy conforms to the patient contours on the table to restrict motion. Tabletop beanbags are connected to a vacuum, and once the patient is positioned, the vacuum removes the air within the bag, which then becomes a rigid mold. The deflated bag conforms to the patient contours on the 2 CBCT ablation software platform. The case is cryoablation of the kidney in a patient with renal cell carcinoma. The tumor is segmented in all three planes and displayed as a 3D volume image (A). The virtual ablation probe (green-pink line) is positioned, and the ablation zone is displayed with different isotherms (B). The software displays tumor segmentation (green circle and pink circle) and coverage relative to the probe position. When the circle delineating the tumor is green, adequate tumor coverage is expected; pink signifies inadequate tumor coverage (C). The needle is positioned with X-ray navigation (D). The cryoablation zone coverage can be corrected according to the final needle position. In this cryoablation case, the iceball obtained (outer circle pink on E and green in F) can also be compared with the segmented tumor (inner green circle on E and green circle in F) to determine whether an adequate margin was obtained N. Abi-Jaoudeh et al.: Multimodality Image Fusion-Guided Procedures 989
Accuracy of EM Tracking
Depending on the exact definition, the accuracy of EM tracking in biopsy and ablation procedures has been reported in a range that is consistent with clinical utility [9, 14, 15] . In an early feasibility study, the overall system accuracy for biopsy procedures with internal needle-tip tracking was \5 mm [9] . For vascular phantom experiments, system accuracy was 2.5 mm [9] . A study on neurosurgical phantoms reported a total target localization error ranging between 0.7 and 3.51 mm [16] using EM tracking. The clinical experience using EM tracking for lung biopsy and ablation procedures was reported with a single skin entry puncture and a median of one needle repositioning [15] . A basic tracking error of 3.8 ± 2.3 mm using EM tracking with skin fiducial patches and needle-tip tracking was reported in 40 patients undergoing biopsy or ablation procedures; this tracking error improved to 2.7 ± 1.6 mm when previous needle positions were used as additional fiducial patch markers [6] . In the study by Penzkofer et al. [17] , 23 patients underwent image-guided interventions using EM-tracking navigation with a reported spatial accuracy of 3.1 ± 2.1 mm. In their report, the radiation dose with EM tracking (732 ± 81 mGy*cm 2 ) was significantly lower compared with that used in conventional CT-guided control nonablation procedures (1343 ± 1054 mGy*cm 2 ) (p = 0.012) [17] . The investigators concluded that the accuracy and decreased radiation dose of EM tracking justified its routine use.
Accuracy of Optical Tracking
Optical tracking is mostly used in surgery in lieu of other stereotactic systems, which are also highly accurate. A deviation of 2.9 mm with optical navigation was reported with CT images as input [11] . The radiation dose was significantly lower in the optical-navigation groups compared with the control arm in both phantom and clinical studies [18] [19] [20] .
Comparison of Optical With EM Tracking
Although studies of optical systems have generally reported higher accuracies in many settings [21] , one phantom study reported similar accuracies of an EM-tracking and two optical systems, and both navigation methods significantly decreased radiation dose and were significantly more accurate in the study than in the control group [18, 22] . However, the line-of-sight requirement has limited the use of optical tracking.
Accuracy of CBCT Navigation
A wide variety of image-guided procedures have been performed with CBCT-based navigation [13] . CBCT-based navigation was used in phantoms for percutaneous imageguided needle placement by Maeda et al. [23] with a technical success rate of 93.8 % (15 of 16) for reaching targets successfully on the first needle pass. The mean distance from the needle tip to the target was 3.83 ± 1.92 mm in the successful passes.
CBCT-based navigation may be used for vertebroplasty [24] , gastrostomy [25] , dacrocystography dacrocystoplaty, and stenting [26] procedures as well as biopsy, drainage, and ablation procedures [27] . In the largest series of 139 patients undergoing various needle-based procedures, the technical success was 100 % (defined as a needle tip position within 5 mm of target). However, accuracy defined as histopathologic diagnosis for biopsy procedures or adequate outcome for therapeutic interventions (i.e., positive aspiration for drainage, successful vertebroplasty, and adequate localization of wire for surgery) was 91.3 % for the overall population [27] . Leschka [28] presented accuracy data for CBCT-based navigation in 12 patients. In their series, the technical success rate was 92 % (11 of 12) with deviation from target of B2.8 mm. One limitation of CBCT is respiratory and patient motion, which can impair registration and decrease accuracy [24] .
Clinical Applications
Percutaneous Nonvascular Procedures EM tracking may facilitate percutaneous image-guided procedures [14, 15, 29] in certain clearly defined cases. EM Fig. 3 PET-guided fusion case with EM tracking. A Enlarged PETavid lymph node in a young man with a history of lymphoma in remission for 10 years. The lesion had been previously biopsied at an outside institution and was negative for recurrence or dedifferentiation. However, the posterior portion of the lesion was not PET-avid. The physician requested a repeat biopsy procedure with 18F-FDG PET guidance. Fiducial patches (B) were used to fuse a procedural CT scan with a US scan in the imaging space. A previous PET-CT scan was fused to the procedural CT scan using anatomic landmarks. C EM-tracking platform. The target is shown as a small blue crosshair (white arrow). The needle is displayed as a yellow cross (not shown but the direction of the virtual path can be seen as the yellow dotted line in certain views). The lower right screen shows a bull eye's view; the red circle converges as the needle advances closer to the target. Real-time US with Doppler interrogation enables assessment of blood vessels in proximity to the target (upper right screen) tracking offers a distinct advantage in cases where the target lesion is not readily visible with conventional imaging guidance, such as ultrasound and CT, without iodinated contrast administration. EM tracking is helpful when lesion visibility is evanescent, e.g., the lesion is only visible in the arterial phase on CT or MRI, by obviating the need for repeat injections or inaccurate use of nearby anatomy to estimate needle positioning. Several studies have reported the usefulness of EM tracking for lesions that are indistinct, heterogeneous, or only visible on PET-CT [4, 8, 30] (Fig. 3) . EM tracking may enhance ablation planning and execution, especially if US visualization is hindered by ablation gas or ice. Ablation-planning software enables visualization of the potential ablation zone, depending on probe type, number, and position, to facilitate attempts for complete tumor coverage (Fig. 4) . Moreover, such planning software can provide iterative feedback during complex ablations that empower the physician to identify tissue at risk for undertreatment, and thereby requiring direct positioning of subsequent ablation probe insertions, if needed [8, [31] [32] [33] .
As with EM tracking, several investigators have presented their experience with CBCT-based navigation whether for routine procedures [13] or more complex cases, such as embolization of jugular paragangliomas [34] or cardiac ablation [35] . Navigation may be most useful when access angles are challenging or when visibility of lesions is limited. Implementation of CBCT-based navigation may become more accessible based on wide availability of C-arms suites in current clinical practice. CBCT may also result in improved patient throughput in clinical settings where the conventional CT scanners are heavily employed for diagnostic studies. EM tracking requires hardware and disposables. EM tracking might be preferable in the pediatric setting because it may have less radiation than CBCT-based navigation using fluoroscopy. However, no study has directly compared the two modalities. Moreover, EM tracking may have strengths when real-time US imaging would be advantageous, such as a lesion surrounded by bowel or in proximity with vasculature. CBCT may have strengths for use with chest procedures including respiratory motion, which can be monitored with registered fluoroscopy (whereas US cannot see into the lung).
Vascular Procedures
EM tracking has been reported as experimental guidance for endovascular procedures, such as stent-graft deployment in phantom and swine studies [9, 10, 36] . Successful deployment of the stent-graft was guided without covering the subclavian artery (and without fluoroscopy). EM tracking could have a role for fenestrated grafts and in operating rooms where advanced angiography systems are often not available.
Software for the fusion of intraoperative CBCT with previously acquired multidetector CT angiography (CTA) Fig. 4 Screenshot displays of EM tracking-based ablation-planning software platform. The software enables the operator to segment the tumor, which is displayed as an orange circle. The expected treatment area is shown as a blue ellipse. Positions of the radiofrequency probe required to achieve the desired tumor coverage are shown as dark blue dots (left panel). The operator can navigate to the desired probe locations and adjust the treatment plan if the needle positioning deviates from the plan. The virtual needle path is overlaid on both the multiplanar reconstructions (purple solid line) and on the ''bull's eye'' view (green crosshairs) (right panel)
or MR angiography (MRA) data sets is commercially available and has shown promising results in decreasing contrast and radiation exposure to patients and facilitating complex procedures [37] . CTA or MRA volumes are overlaid with an intraoperative low-dose CBCT; this step is performed automatically or by selecting common landmarks, such as calcifications, clips, or vessel borders, thus excluding the need for contrast injection. 3D CTA/MRA volumes can then be used as the background map for realtime navigation and deployment of endovascular devices and thus replace multiple 2D angiograms, 2D roadmaps, or ''fluorofade'' (Fig. 5 ). An additional advantage of 3D-data set fusion is that movements of the C-arm, flat detector, and table are compensated, integrated, and corrected, thus making the 3D data set usable throughout the procedure.
CBCT fusion imaging with multidetector CT was used to guide fenestrated endograft placement in 40 patients [37] . The investigators compared a CBCT-fusion navigation group with historical controls and found a significant decrease of contrast dose needed (50 cc in the CBCT group vs. 100 cc in the conventional imaging group [p \ 0.0001]). There was a trend of decreased fluoroscopy and procedure times, but this did not reach statistical significance. Moreover, postprocedural CBCT correctly detected endoleaks, which were treated with the patient still on the table.
Postprocedural CBCT specificity had a high enough sensitivity to result in no endoleaks detected on predischarge diagnostic CT in patients with a negative postprocedural CBCT. Recently, CBCT-based navigation was also used to deploy a thoracic stent-graft without the need for contrast administration [38] .
Several other case series detail the use of a 3D roadmap, which provides an overlay of CT landmarks on regular DSA, to enable successful completion of challenging cases (e.g., percutaneous closure of an atrial septal defect or catheterization of a graft in a patient with challenging surgically distorted anatomy and history of failed Fig. 5 Stent-graft deployment for infrarenal abdominal aortic aneurysm using preoperative CTA as a 3D roadmap overlaid on live fluoroscopy. A Markers are displayed on the renal arteries to be preserved (red and blue circles). One inferior right accessory renal artery was covered and one lower left accessory renal artery embolized before stent-graft deployment to avoid type II endoleaks. Two guidewires are visible in the projection of the aortic lumen. B Positioning of the stent-graft using CTA as a roadmap enables a view of the aortic neck without requiring a standard angiogram. C Deployment of the first two struts of the stent-graft under 3D CTA roadmap control. D Deployment of the entirety of the aorto-bi-iliac component of the stent-graft. Note the deformation of the iliac arteries due to stiff guidewires and the stiffness of the stent-graft catheterization attempt) [39] . CBCT-based navigation may facilitate angle selection during translumbar central venous catheter placement, which is notorious for kinking due to the IVC access angle [24] , or transjugular intrahepatic portosystemic shunt placement (Fig. 6) .
In 2010, Deschamps et al. [40] published their experience with a CBCT treatment-planning software on 18 patients undergoing a total of 25 chemoembolizations. The investigators examined tumor delineation and feedingvessel segmentation using a regular angiogram, the 3D data set of CBCT, and the CBCT treatment-planning software. They concluded that the treatment-planning software was significantly more sensitive in determining the vascularity of a tumor and that interobserver correlation was significantly higher with its use, thus making results more reproducible. The investigators did not use CBCT navigation for catheter positioning, which was performed with conventional angiographic techniques; however, the CBCT software was used for ''embolization planning,'' e.g., to predetermine the number and locations of feeding vessels.
CBCT navigation for catheter positioning may be helpful in decreasing contrast and radiation of ''roadmaps/fluorofades'' for catheter-position confirmation (Fig. 7) . Bronchoscopy EM tracking during bronchoscopy has been documented as safe and beneficial for peripheral, small lesions, thus improving diagnosis in some settings from 35 to 60 to 70 % [41, 42] . However, most of the studies are retrospective case series [43] . Schwartz et al. found a diagnostic yield with EM-guided biopsy procedures of 69 % [42] . Gildea et al. [44] prospectively examined the diagnostic yield of EM-tracked bronchoscopy in 60 patients. The target was reached in 100 % of cases with diagnostic tissue obtained in 74 % of peripheral lesions and 100 % of peripheral lymph nodes sampled. More than half of the lesions were \2 cm in size. Several EM bronchoscopy systems with flexible tracked instruments are commercially available [41] . CBCT platforms are also being investigated as reference imaging to enable tracked bronchoscopy [41] .
Prostate EM tracking of transrectal US enables the use of MRI imaging outside of the MRI for fusion-guided targeted prostate biopsy procedures using both the real-time feedback of US and the tissue characterization of multiparametric MRI (including MR spectroscopy, diffusionweighted imaging, and dynamic contrast-enhanced MRI [45] [46] [47] ). The MRI images are used to select and navigate biopsy procedures to targets identified on MRI after coregistration of the US to the MRI system with motion compensation. Such fusion-targeted prostate biopsy procedures can be performed in the office setting and markedly improve the detection yield of prostate biopsy procedures compared with standard random transrectal USguided biopsy procedures (Fig. 8) . In patients with suspicious lesions identified on MRI, the targeted fusion biopsy procedure yields approximately double the positive biopsy rate of standard random biopsy procedures [47] . In addition, the technology can be used to map the location of biopsy for subsequent repeat biopsy procedure or focal therapy, which may be important in patients with low Gleason scores undergoing watchful waiting or surveillance [46] .
Future Directions
The safety and feasibility of multimodality image fusionguided navigation techniques have been shown, and their clinical efficacy and indications are being defined. Imagefusion navigation, although first used in the operating room for surgical navigation, is currently being used in endoscopic, bronchoscopic, urologic, and percutaneous nonvascular and vascular interventional procedures.
These technologies are especially useful in approaching lesions that are only visualized with certain modalities or phases, i.e., PET-CT, MRI, or arterial-phase CT. Navigation technologies are also potentially useful in complex or large ablations that require multiple overlapping ablation locations. The ablation-planning software can aid the physician to depict not only the target tissue but also superimposed planned ablation zones. This could enable or facilitate more complete tumor coverage and aid the repositioning of subsequent needles to predefined tumor tissue (or tissue targets at risk for undertreatment) [8] . CBCT-based techniques for catheter-and needle-based navigation have also been developed in recent years and provide some similar functionality but with some key differences.
In the near future, registration and throughput is expected to become faster and more integrated. Indeed, combinations of navigation technologies are becoming more widespread in minimally invasive medicine as is the use of preprocedural imaging during procedures performed by staff in nonradiology disciplines. This multidisciplinary approach is often most effective with an active role played by the interventional radiologist. As these technologies evolve, their application to more complex procedures will better define their exact clinical roles and utilities. It is possible that multimodality imaging will lead to improved use of multiparametric tissue characterization (in which layers of 3D data are matched to each other). This could further guide interventional therapies where navigation systems will provide the registration tools and report the location for cellular imaging devices or microscope/needles. Fusion-guided biopsy procedures will become not only a tool for drug discovery but also a vital tool for establishing specific drug combinations to which a specific tumor will respond. As the role of the interventional radiologist expands within oncology, PET-guided ablation or other multimodality fusion-navigation tools could help refine the term ''molecular interventions'' and further personalize the minimally invasive care of cancer patients. Fig. 8 EM-tracked prostate biopsy. A The target is identified on MRI (red dot) based on multiparametric MRI (MR spectroscopy, T2, diffusion weighting, and dynamic contrast enhanced MRI. B, C Intraprocedural ultrasound is registered in the virtual space, and corresponding anatomic location in 3D space on the MRI is codisplayed. The target is marked on US, and the MRI images and needle location are displayed in relation to the MRI-defined target development agreements (NIH and Philips Health Care). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the United States Government.
